HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kieren A Marr Selected Research

Fluconazole (Zonal)

9/2013Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
4/2012Administration of voriconazole in patients with renal dysfunction.
2/2012Invasive fungal bezoar requiring partial cystectomy.
12/2010Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
8/2008Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.
5/2006Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
10/2004Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation.
5/2004Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.
2/2004Cyclophosphamide metabolism is affected by azole antifungals.
2/2004Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kieren A Marr Research Topics

Disease

30Infections
01/2022 - 01/2002
30Aspergillosis
12/2021 - 08/2002
13Mycoses (Diseases, Fungus)
12/2021 - 01/2002
13Invasive Fungal Infections
09/2013 - 05/2003
12Neutropenia
06/2010 - 04/2002
10Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 04/2002
8Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 11/2006
5Neoplasms (Cancer)
01/2022 - 04/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2013 - 10/2006
3COVID-19
01/2022 - 01/2021
3Cryptococcosis
01/2020 - 05/2003
3Central Nervous System Diseases (CNS Diseases)
01/2020 - 06/2010
3Lymphopenia (Lymphocytopenia)
10/2014 - 12/2002
3Fever (Fevers)
02/2013 - 02/2004
3Pneumonia (Pneumonitis)
02/2012 - 10/2006
3Candidiasis (Moniliasis)
10/2004 - 05/2003
2Meningoencephalitis
11/2021 - 01/2018
2Cryptococcal Meningitis
03/2019 - 01/2016
2Diarrhea
04/2017 - 04/2012
2Clostridium Infections
02/2017 - 10/2013
2Mucositis
02/2017 - 10/2013
2Virus Diseases (Viral Diseases)
10/2014 - 12/2002
2Leukemia
06/2014 - 08/2002
2Inflammation (Inflammations)
02/2012 - 03/2008
2Opportunistic Infections (Opportunistic Infection)
01/2012 - 08/2002
2Candidemia
06/2009 - 05/2006
2Fusariosis
05/2004 - 05/2003
1Liver Diseases (Liver Disease)
01/2022
1Coinfection
01/2022
1Vascular Diseases (Vascular Disease)
01/2022
1Multiple Myeloma
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Coccidioidomycosis
03/2019
1Blastomycosis
03/2019
1Histoplasmosis
03/2019
1Disease Susceptibility (Diathesis)
01/2018
1Viral Meningitis
01/2018
1Cytomegalovirus Infections (Inclusion Disease)
10/2016
1Eye Diseases (Eye Disease)
02/2016
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2016
1Digestive System Diseases
02/2016
1Kidney Diseases (Kidney Disease)
10/2014
1Chronic Kidney Failure (Chronic Renal Failure)
10/2014
1Chronic Renal Insufficiency
10/2014
1Viremia
10/2014
1Yellow Fever
05/2013

Drug/Important Bio-Agent (IBA)

11Voriconazole (Vfend)FDA LinkGeneric
02/2016 - 08/2002
11Fluconazole (Zonal)FDA LinkGeneric
09/2013 - 05/2002
8galactomannanIBA
12/2021 - 08/2004
7Amphotericin B (Amphotericin)FDA LinkGeneric
02/2012 - 04/2002
6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 12/2002
6Pharmaceutical PreparationsIBA
08/2021 - 05/2002
6EnzymesIBA
03/2019 - 08/2004
4AntigensIBA
11/2018 - 01/2011
4Antifungal AgentsIBA
06/2009 - 08/2005
3Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2015
3Antiviral Agents (Antivirals)IBA
10/2016 - 05/2013
3EchinocandinsIBA
08/2011 - 09/2004
3Caspofungin (Cancidas)FDA Link
08/2011 - 09/2004
3HLA Antigens (Human Leukocyte Antigens)IBA
10/2008 - 05/2004
3AzolesIBA
08/2008 - 09/2004
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 01/2016
2polyglucosanIBA
11/2018 - 04/2006
2Penicillins (Penicillin)FDA Link
02/2013 - 04/2012
2Micafungin (FK463)FDA Link
08/2011 - 11/2006
2Prednisone (Sone)FDA LinkGeneric
06/2010 - 03/2009
2LipidsIBA
08/2008 - 08/2003
2Itraconazole (Sporanox)FDA LinkGeneric
02/2004 - 02/2004
1remdesivirIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
09/2021
1Enfuvirtide (Fuzeon)FDA Link
01/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
1AntibodiesIBA
03/2019
1Monoclonal AntibodiesIBA
11/2018
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
02/2017
1Ganciclovir (Cytovene)FDA LinkGeneric
10/2016
1FoscarnetFDA LinkGeneric
10/2016
1Cidofovir (Vistide)FDA Link
10/2016
1isavuconazoleIBA
02/2016
1Interleukin-12 (IL 12)IBA
10/2014
1Cephalosporins (Cephalosporin Antibiotics)IBA
10/2013
1nucleic acid probe 1IBA
08/2013

Therapy/Procedure

29Therapeutics
01/2022 - 01/2002
14Transplantation
01/2020 - 04/2002
14Hematopoietic Stem Cell Transplantation
02/2017 - 01/2002
5Drug Therapy (Chemotherapy)
01/2018 - 11/2006
5Cell Transplantation
01/2015 - 08/2002
5Stem Cell Transplantation
10/2013 - 08/2002
3Salvage Therapy
10/2016 - 05/2003
3Induction Chemotherapy
06/2014 - 10/2006
3Organ Transplantation
11/2012 - 01/2011
2Kidney Transplantation
01/2021 - 10/2014
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2020 - 10/2006
1Immunomodulation
01/2021
1Length of Stay
01/2021
1Art Therapy
01/2020
1Ventriculostomy
01/2020
1Biological Therapy
01/2018
1Plasmapheresis
04/2017
1Renal Dialysis (Hemodialysis)
10/2014